The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
Phillip Scheinberg(National Heart Lung and Blood Institute), Daniel C. Douek(Institut de Recherche Vaccinale), A. John Barrett(National Institutes of Health), Brenna J. Hill(National Institute of Allergy and Infectious Diseases), Louis J. Picker(Oregon National Primate Research Center), Mario Roederer(National Institutes of Health), David A. Price(University Hospital of Wales), Jan Joseph Melenhorst(National Heart Lung and Blood Institute), Jason M. Brenchley(National Institutes of Health), Nancy F. Hensel(National Heart Lung and Blood Institute), Pratip K. Chattopadhyay(National Institute of Allergy and Infectious Diseases)
Cited by 84
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k